Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0GL2X
|
|||
| Former ID |
DNC014036
|
|||
| Drug Name |
1,3-dibenzyl urea
|
|||
| Synonyms |
1,3-Dibenzylurea; N,N'-Dibenzylurea; 1466-67-7; sym-Dibenzylurea; Urea, N,N'-bis(phenylmethyl)-; 1,3-dibenzyl urea; 1,3-Dibenzyl-urea; CHEMBL504463; KATOLVAXCGIBLO-UHFFFAOYSA-N; N-benzyl[benzylamino]carboxamide; dibenzylurea; EINECS 215-984-9; NSC408007; NSC 408007; N,N'-Dibenzylharnstoff; AI3-19855; AC1Q5OY5; AC1L2IW5; Oprea1_448978; Urea,N'-bis(phenylmethyl)-; SCHEMBL714625; Urea,N,N'-bis(phenylmethyl)-; DTXSID3061710; ZINC84096; KS-00001BSB; CTK4C5047; MolPort-000-421-383; HMS1697A06; STK008269; BDBM50248768; SBB023417; CCG-48904
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H16N2O
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CNC(=O)NCC2=CC=CC=C2
|
|||
| InChI |
1S/C15H16N2O/c18-15(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10H,11-12H2,(H2,16,17,18)
|
|||
| InChIKey |
KATOLVAXCGIBLO-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1466-67-7
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Transient receptor potential cation channel V1 (TRPV1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Inflammatory mediator regulation of TRP channels | ||||
| NetPath Pathway | IL2 Signaling Pathway | |||
| Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | |||
| Trk receptor signaling mediated by PI3K and PLC-gamma | ||||
| Reactome | TRP channels | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Rare dipeptide and urea derivatives from roots of Moringa oleifera as potential anti-inflammatory and antinociceptive agents. Eur J Med Chem. 2009 Jan;44(1):432-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.